AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MOUNT RIDLEY MINES LTD

0.030

-0.001-3.23%

Volume:917.89K

Turnover:28.09K

Market Cap:39.83M

PE:-17.79

High:0.031

Open:0.031

Low:0.030

Close:0.031

52wk High:0.087

52wk Low:0.002

Shares:1.33B

Float Shares:1.07B

Volume Ratio:0.38

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.002

EPS(LYR):-0.003

ROE:-89.47%

ROA:-39.33%

PB:21.10

PE(LYR):-8.83

Loading ...

Overview Company News Filings

Mount Ridley Mines - Trading Halt Requested Pending Announcement on Processing Technology and Metallurgical Results

THOMSON REUTERS

Mount Ridley Mines Ltd-appointment of Chief Technology Officer

THOMSON REUTERS

We Think Mount Ridley Mines (ASX:MRD) Can Afford To Drive Business Growth

Simply Wall St.

Australia's Mount Ridley Gains on CSIRO Co-funded Scandium Project

MRD Spinoff And $250 Million Convertible Notes Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Simply Wall St.

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan

Mount Ridley Mines Ltd-Phase 1 Metallurgical Testwork Commences

THOMSON REUTERS

Mount Ridley Mines Ltd-Appointment of Technical Advisor - Metallurgy & Processing

THOMSON REUTERS

Solowin Holdings signs MOU with SC Ventures to incubate AI payments project AGENPAY

Mount Ridley Mines Ltd-Exploration Update

THOMSON REUTERS

BRIEF-Mount Ridley Mines Seeks Trading Halt Pending Material Mineral Resource Estimate Announcement

BRIEF-Mount Ridley Mines Appoints Allister Caird As Managing Director And CEO

Mount Ridley Mines Ltd - Appoints Allister Caird as Managing Director and CEO

THOMSON REUTERS

Mount Ridley Mines - David Wall Appointed Non-Executive Chairman

THOMSON REUTERS

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

How Strong 2025 Results and MRD-Focused 2026 Guidance At Adaptive Biotechnologies (ADPT) Has Changed Its Investment Story

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MRD.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MRD.AU\",,,,,undefined,":{"symbol":"MRD.AU","market":"AU","secType":"STK","nameCN":"MOUNT RIDLEY MINES LTD","latestPrice":0.03,"timestamp":1787292720000,"preClose":0.031,"halted":0,"volume":917892,"delay":0,"changeRate":-0.03225806451612906,"nameEN":"MOUNT RIDLEY MINES LTD","floatShares":1070873553,"shares":1327582159,"eps":-0.001686,"marketStatus":"Market Closed","change":-0.001,"latestTime":"08-21 16:12:00 AEST","open":0.031,"high":0.031,"low":0.03,"amount":28085,"amplitude":0.032258,"askPrice":0.031,"askSize":243166,"bidPrice":0.03,"bidSize":361436,"shortable":3,"etf":0,"ttmEps":-0.001686,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.031,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.384956995928117,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MRD.AU","preClose":0.031,"auctionPrice":0.03,"auctionVolume":3,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292493685}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MRD.AU\",,,,,undefined,":{"symbol":"MRD.AU","floatShares":1070873553,"roa":"-39.33%","roe":"-89.47%","lyrEps":-0.003396,"volumeRatio":0.384956995928117,"shares":1327582159,"dividePrice":0,"high":0.031,"amplitude":0.032258,"preClose":0.031,"low":0.03,"week52Low":0.002,"pbRate":"21.10","psRate":"89.40","week52High":0.087,"institutionHeld":0,"latestPrice":0.03,"committee":0.195616,"eps":-0.001686,"divideRate":0,"volume":917892,"delay":0,"ttmEps":-0.001686,"open":0.031,"prevYearClose":0.033,"prevWeekClose":0.032,"prevMonthClose":0.025,"prevQuarterClose":0.021,"fiveDayClose":0.032,"twentyDayClose":0.027,"sixtyDayClose":0.026},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-12-17","symbol":"MRD.AU","defaultRemindTime":1734390000000,"type":"split","dateTimestamp":1734354000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2024-11-15","symbol":"MRD.AU","defaultRemindTime":1731625200000,"type":"split","dateTimestamp":1731589200000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRD.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658060537","title":"Mount Ridley Mines - Trading Halt Requested Pending Announcement on Processing Technology and Metallurgical Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658060537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658060537?lang=en_us&edition=fundamental","pubTime":"2026-08-10 07:44","pubTimestamp":1786319080,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260809:nFWN44500U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRD.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653878196","title":"Mount Ridley Mines Ltd-appointment of Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653878196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653878196?lang=en_us&edition=fundamental","pubTime":"2026-07-22 07:44","pubTimestamp":1784677459,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUE185DK3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","MRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955007","title":"We Think Mount Ridley Mines (ASX:MRD) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955007","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649955007?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:35","pubTimestamp":1783456536,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-mrd/mount-ridley-mines-shares/news/we-think-mount-ridley-mines-asxmrd-can-afford-to-drive-busin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-mrd/mount-ridley-mines-shares/news/we-think-mount-ridley-mines-asxmrd-can-afford-to-drive-busin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MRD.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649832601","title":"Australia's Mount Ridley Gains on CSIRO Co-funded Scandium Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2649832601","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649832601?lang=en_us&edition=fundamental","pubTime":"2026-07-07 13:45","pubTimestamp":1783403147,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mount Ridley gains on CSIRO co-funded scandium project** Shares of Australia's Mount Ridley MinesMRD.AXsoar as much as 18.2% to A$0.026, their highest level since June 22** Shares eye their biggest pct gain since March 24** Mineral exploration cogetsco-funding from CSIRO, Australia's national science agency, for A$104,000  research project to advance scandium downstream development opportunities** CSIRO will contribute up to A$50,000, with Mount Ridley co-funding the balance, co says** Near 2.5 million shares trade hands, about 2.8x 30-day average** Stock down 24.2% YTD, including session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","MRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644715644","title":"MRD Spinoff And $250 Million Convertible Notes Could Be A Game Changer For Adaptive Biotechnologies (ADPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715644","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644715644?lang=en_us&edition=fundamental","pubTime":"2026-06-17 14:25","pubTimestamp":1781677527,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies recently completed a US$250,000,000 private offering of unsecured, senior, callable convertible notes due July 1, 2031, while also outlining plans to separate its profitable Minimal Residual Disease (MRD) unit from its Immune Medicine business.\nThe combination of business separation and new convertible debt signals a meaningful reshaping of Adaptive’s capital structure and business focus, with MRD positioned as the primary engine and Immune Medicine seeking growth...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/mrd-spinoff-and-250-million-convertible-notes-could-be-a-gam","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/mrd-spinoff-and-250-million-convertible-notes-could-be-a-gam","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","ADPT","MRD.AU","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638667234","title":"PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2638667234","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638667234?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:00","pubTimestamp":1779966000,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May 28, 2026 /PRNewswire/ -- PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor -targeted CAR T-cell therapy, have been selected for an oral presentation at the 2026 Congress of the European Hematology Association .\"When cancer progresses following CD19 CAR T therapy, patients face a significant unmet medical need, with very limited treatment options remaining,\" said Larry W. Kwak, M.D., Ph.D., scientific founder of PeproMene Bio. \"These durable CRs clinically validate BAFF-R as a novel target, while the favorable safety profile observed to date may support future use in outpatient community oncology settings and further exploration in refractory autoimmune diseases.\". PeproMene Bio, Inc. is a clinical-stage biotech company in Irvine, California developing novel therapies to treat cancers and immune disorders. For more information, c","market":"fut","thumbnail":"https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pepromene-bio-announces-oral-presentation-at-eha-2026-highlighting-favorable-safety-and-durable-responses-with-pmb-ct01-baff-r-car-t-cell-therapy-in-b-cell-lymphomas-including-after-prior-cd19-car-t-cell-failure-302783633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","IE00B19Z4B17.USD","LU2065731478.USD","CRS","IE00B7SZL793.SGD","BK4006","BK4187","IE0031619046.USD","CAR","CR","CRS.AU","IE00B66KJ199.SGD","MRD.AU","BK7095","BK4230","LU0963586101.USD","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637395296","title":"Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2637395296","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637395296?lang=en_us&edition=fundamental","pubTime":"2026-05-22 14:45","pubTimestamp":1779432300,"startTime":"0","endTime":"0","summary":"Satellite symposium and exhibition engagement highlighted strong physician interest in MRD, MCED, and evidence-driven adoption of genomic testing.TAIPEI, May 22, 2026 /PRNewswire/ -- Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference , marking its first major oncology conference presence in Taiwan.Scientific Program and Faculty HighlightsThe event brought together a distinguished faculty of Taiwan-based and regional experts to discuss the evolving role of liquid biopsy in precision oncology, with a focus on multi-omics, artificial intelligence, MRD, and MCED.Assistant Professor Aaron Tan Chia-Ken  delivered a pan-cancer perspective on the value of liquid biopsy and multi-omics across all stages of cancer care. He illustrated the broad clinical utility of liquid biopsy — from genotyping and treatment selection in advanced disease, ctDNA ","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2985328/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2985328/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-showcases-ai-powered-multi-omics-liquid-biopsy-innovations-at-tjcc-2026-advancing-precision-oncology-in-taiwan-302779916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","DNA","BK4543","NGS","TAT","BK4109","BK4121","NGS.AU","MRD.AU","TAT.AU","ARTY","AI","BK4585","BK7078","BK7111","DNA.AU","BK4587","AIPO","BK4139","AGIX","BK4023","AIYY","BK4588","BK4179","BK4551","BK7095","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636860800","title":"Mount Ridley Mines Ltd-Phase 1 Metallurgical Testwork Commences","url":"https://stock-news.laohu8.com/highlight/detail?id=2636860800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636860800?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:23","pubTimestamp":1779229388,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUE8L1WZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","MRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537550","title":"Mount Ridley Mines Ltd-Appointment of Technical Advisor - Metallurgy & Processing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631537550?lang=en_us&edition=fundamental","pubTime":"2026-04-29 07:01","pubTimestamp":1777417267,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUE6XPD2P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRD.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630312095","title":"Solowin Holdings signs MOU with SC Ventures to incubate AI payments project AGENPAY","url":"https://stock-news.laohu8.com/highlight/detail?id=2630312095","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630312095?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:07","pubTimestamp":1777320439,"startTime":"0","endTime":"0","summary":"Solowin Holdings  signed a non-binding MoU with SC Ventures on April 27, 2026 to jointly incubate AI payments project AGENPAY.Partnership targets development of API retrieval capabilities, payment routing infrastructure.Collaboration also plans integration of ecosystem proof-of-concepts in Hong Kong.AGENPAY aims to improve payments efficiency, strengthen risk management, cut transaction costs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL4R3ZFt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","BK4127","IE00BKPKM429.USD","BK4588","BK7095","LU0314104364.USD","BK5078","GROW.UK","LU2095319765.USD","MRD.AU","AXG","BK4585","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629404069","title":"Mount Ridley Mines Ltd-Exploration Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629404069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629404069?lang=en_us&edition=fundamental","pubTime":"2026-04-22 07:21","pubTimestamp":1776813686,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE80VJ3N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","MRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620358272","title":"BRIEF-Mount Ridley Mines Seeks Trading Halt Pending Material Mineral Resource Estimate Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620358272","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620358272?lang=en_us&edition=fundamental","pubTime":"2026-03-20 06:25","pubTimestamp":1773959141,"startTime":"0","endTime":"0","summary":"BRIEF-Mount Ridley Mines Seeks Trading Halt Pending Material Mineral Resource Estimate AnnouncementMarch 20 (Reuters) - Mount Ridley Mines Ltd MRD.AX:SEEKS TRADING HALT PENDING MATERIAL MINERAL RESOURCE ESTIMATE ANNOUNCEMENTFurther company coverage: MRD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN4071C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRD.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618993136","title":"BRIEF-Mount Ridley Mines Appoints Allister Caird As Managing Director And CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2618993136","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618993136?lang=en_us&edition=fundamental","pubTime":"2026-03-11 08:48","pubTimestamp":1773190092,"startTime":"0","endTime":"0","summary":"BRIEF-Mount Ridley Mines Appoints Allister Caird As Managing Director And CEOMarch 11  - Mount Ridley Mines Ltd MRD.AX:APPOINTS ALLISTER CAIRD AS MANAGING DIRECTOR AND CEODAVID WALL APPOINTED NON-EXECUTIVE CHAIRMANPETER CHRISTIE TRANSITIONS FROM CHAIRMAN TO NON-EXECUTIVE DIRECTORFurther company coverage: MRD.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nFWN3ZY1QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","MRD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618967305","title":"Mount Ridley Mines Ltd - Appoints Allister Caird as Managing Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2618967305","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618967305?lang=en_us&edition=fundamental","pubTime":"2026-03-11 06:52","pubTimestamp":1773183148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1QL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRD.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618673099","title":"Mount Ridley Mines - David Wall Appointed Non-Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2618673099","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618673099?lang=en_us&edition=fundamental","pubTime":"2026-03-11 06:52","pubTimestamp":1773183148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1QL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRD.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614187008","title":"Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics","url":"https://stock-news.laohu8.com/highlight/detail?id=2614187008","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614187008?lang=en_us&edition=fundamental","pubTime":"2026-02-27 07:53","pubTimestamp":1772149980,"startTime":"0","endTime":"0","summary":"TruPath Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases. 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on allNovaSeq X systems, advancing precision medicine and delivering compounded value for NovaSeq X customers. AtAGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions. SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Illumina Inc. , a global leader in DNA sequencing and array-based technologies, today announced a suite of powerful advancements that will significantly accelerate the next era of genomic discovery. Unveiled at the Advances in Genome Biology and Technology  2026 conference, the announcements include the launch of TruPath Genome, a new standard in genomic insight; a groundbreaking roadmap for the NovaSeq X Series; an","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2921422/image.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2921422/image.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/illumina-launches-trupath-genome-unveils-novaseq-x-roadmap-and-drives-cancer-breakthroughs-with-connected-multiomics-302699118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STR.AU","BK4535","MRD.AU","BK4548","BK4585","BK4121","BK7120","BK4534","BK4588","ILMN","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612452502","title":"How Strong 2025 Results and MRD-Focused 2026 Guidance At Adaptive Biotechnologies (ADPT) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452502","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452502?lang=en_us&edition=fundamental","pubTime":"2026-02-17 19:25","pubTimestamp":1771327528,"startTime":"0","endTime":"0","summary":"In early February 2026, Adaptive Biotechnologies reported full-year 2025 results showing sales of US$276.98 million versus US$178.96 million a year earlier, and a net loss of US$59.5 million versus US$159.49 million, with basic loss per share from continuing operations improving to US$0.39 from US$1.08.\nOn the same day, the company issued 2026 guidance for its measurable residual disease (MRD) business, projecting full-year revenue between US$255 million and US$265 million while withholding...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/how-strong-2025-results-and-mrd-focused-2026-guidance-at-ada","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/how-strong-2025-results-and-mrd-focused-2026-guidance-at-ada","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","BK4121","ADPT","MRD.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}